Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.

AusPAR: Irinotecan (as sucrosofate)

Australian public assessment report

AusPAR

Australian Public Assessment Report for irinotecan (as sucrosofate) [PDF, 703.05 KB]

Australian Public Assessment Report for irinotecan (as sucrosofate) [DOCX, 720.18 KB]

AusPAR Attachment 1: Product Information for irinotecan (as sucrosofate) [PDF, 323.42 KB]

AusPAR Attachment 1: Product Information for irinotecan (as sucrosofate) [DOCX, 221.98 KB]

AusPAR Attachment 2: Extract from the Clinical Evaluation Report for irinotecan (as sucrosofate) [PDF, 1.83 MB]

AusPAR Attachment 2: Extract from the Clinical Evaluation Report for irinotecan (as sucrosofate) [DOCX, 7.6 MB]

Device/Product Name

Onivyde

Active ingredients

Irinotecan (as sucrosofate)

AusPAR Date

5 October 2017

Published

17 October 2017

Submission Number

PM-2015-03196-1-4

Submission Type

New chemical entity

Decision

Approved

Product types

Prescription medicines